CellTolerance
Food Intolerance (e.g., IBS)
Commercial LaunchActive
Key Facts
Indication
Food Intolerance (e.g., IBS)
Phase
Commercial Launch
Status
Active
Company
About Mauna Kea Technologies
Mauna Kea Technologies' mission is to transform medical decision-making by providing real-time cellular visualization during diagnostic and therapeutic procedures. Its flagship Cellvizio® platform, a confocal laser endomicroscopy system, has achieved significant commercial traction with over 100,000 patient procedures, 1,300+ clinical publications, and more than 20 FDA clearances. The company's strategy focuses on expanding indications, integrating AI, and leveraging strategic partnerships with players like Johnson & Johnson and Telix Pharmaceuticals to drive global adoption and penetrate new markets.
View full company profile